Cargando…
miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(−) symporter in thyroid cancer by regulating MAPK signaling pathway
BACKGROUND: Serum miRNAs profiles between papillary thyroid carcinoma (PTC) patients with non-(131)I and (131)I-avid lung metastases are differentially expressed. These miRNAs have to be further validated and the role of these miRNAs in the molecular function level of thyroid cancer cell lines has n...
Autores principales: | Shen, Chen-Tian, Qiu, Zhong-Ling, Song, Hong-Jun, Wei, Wei-Jun, Luo, Quan-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919890/ https://www.ncbi.nlm.nih.gov/pubmed/27342319 http://dx.doi.org/10.1186/s13046-016-0377-0 |
Ejemplares similares
-
The Thyroid Na+/I- Symporter: Molecular Characterization and Genomic Regulation
por: Alotaibi, Hani, et al.
Publicado: (2017) -
Redox Homeostasis in Thyroid Cancer: Implications in Na(+)/I(−) Symporter (NIS) Regulation
por: Cazarin, Juliana, et al.
Publicado: (2022) -
Implications of Na(+)/I(-) Symporter Transport to the Plasma Membrane for Thyroid Hormonogenesis and Radioiodide Therapy
por: Martín, Mariano, et al.
Publicado: (2018) -
Selumetinib Activity in Thyroid Cancer Cells: Modulation of Sodium Iodide Symporter and Associated miRNAs
por: Wächter, Sabine, et al.
Publicado: (2018) -
Physiological sodium concentrations enhance the iodide affinity of the Na(+)/I(−) symporter
por: Nicola, Juan P., et al.
Publicado: (2014)